Valneva to launch trial for booster use of its COVID-19 vaccine candidate | Reuters
French drugmaker Valneva said on Wednesday it will conduct a trial about the use of its COVID-19 vaccine candidate VLA2001 as a booster jab following a mRNA vaccination or natural infection.